ArticleDiabetology & metabolic syndrome2018

Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance.

Sachiko HattoriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.